Showing results (1-10 of 51) with videos related to
Sort By:
Pageof 6
Military Medicine|June 3, 2009
Methicillin-resistant Staphylococcus aureus infections in U.S. service members deployed to IraqStephen S Roberts, Robert J KazragisCancer Biology & Therapy|January 30, 2013
The translocator protein (TSPO) ligand PK11195 induces apoptosis and cell cycle arrest and sensitizes to chemotherapy treatment in pre- and post-relapse neuroblastoma cell linesMaria C Mendonça-Torres, Stephen S RobertsTranslational Oncology|August 7, 2010
Comparison of the side populations in pretreatment and postrelapse neuroblastoma cell linesThomas C Newton, Karen Wolcott, Stephen S RobertsJournal of Pediatric Hematology/Oncology|April 24, 2018
Romiplostim for Immune Thrombocytopenia in Neuroblastoma Patients Receiving ChemotherapyHannah Fassel, James B Bussel, Stephen S Roberts, et al.Frontiers in Oncology|August 25, 2015
Immunotherapy of Childhood SarcomasStephen S Roberts, Alexander J Chou, Nai-Kong V CheungPediatric Blood & Cancer|January 24, 2017
Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II studyShakeel Modak, Brian H Kushner, Ellen Basu, et al.Frontiers in Oncology|March 16, 2019
Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal TumorsMichael V Ortiz, Stephen S Roberts, Julia Glade Bender, et al.Pathology Oncology Research : POR|April 22, 2009
GABA receptor expression in benign and malignant thyroid tumorsStephen S Roberts, Maria Cecilia Mendonça-Torres, Kirk Jensen, et al.JCO Precision Oncology|August 10, 2023
Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in AdultsJessica Stiefel, Brian H Kushner, Stephen S Roberts, et al.JAMA Oncology|October 17, 2018
Humanized 3F8 Anti-GD2 Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma: A Phase 1 Clinical TrialBrian H Kushner, Irene Y Cheung, Shakeel Modak, et al.Pageof 6